180 related articles for article (PubMed ID: 19856056)
21. Placental-site trophoblastic tumor with PET scan-detected surgically treated lung metastasis.
Nieves L; Hoffman J; Allen G; Currie J; Sorosky JI
Int J Clin Oncol; 2008 Jun; 13(3):263-5. PubMed ID: 18553238
[TBL] [Abstract][Full Text] [Related]
22. Placental site trophoblastic tumor presenting as subaponeurotic metastasis.
Aoki Y; Kase H; Kashima K; Yahata T; Tanaka K
Int J Gynecol Cancer; 2005; 15(2):385-8. PubMed ID: 15823131
[TBL] [Abstract][Full Text] [Related]
23. A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease.
Hartenbach EM; Saltzman AK; Carter JR; Twiggs LB
Gynecol Oncol; 1995 Jan; 56(1):105-8. PubMed ID: 7529741
[TBL] [Abstract][Full Text] [Related]
24. Management of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine chemotherapy.
Cyriac S; Rajendranath R; Sridevi V; Sagar TG
J Reprod Med; 2011; 56(5-6):219-23. PubMed ID: 21682117
[TBL] [Abstract][Full Text] [Related]
25. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
26. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
[No Abstract] [Full Text] [Related]
27. Successful salvage therapy of resistant gestational trophoblastic disease with etoposide, methotrexate, actinomycin-D, etoposide, cisplatin (EMA/EP).
Bilgin T; Ozan H; Ozuysal S; Ozkan L
Arch Gynecol Obstet; 2004 Jan; 269(2):159-60. PubMed ID: 14648186
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous uterine perforation mimicking ectopic pregnancy as the initial presentation of placental site trophoblastic tumor.
Lin HW; Shieh CS; Chen LM; Yang YT; Han CP
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Sep; 64(9):545-50. PubMed ID: 11768287
[TBL] [Abstract][Full Text] [Related]
29. Plasma methotrexate levels in patients receiving etoposide, methotrexate, actinomycin, cyclophosphamide, and vincristine (EMA-CO) chemotherapy for trophoblastic neoplasia.
Kohorn EI
Gynecol Oncol; 1993 Sep; 50(3):300-4. PubMed ID: 8406191
[TBL] [Abstract][Full Text] [Related]
30. Placental site trophoblastic tumor on endometrial polyp: a case report.
Patacchiola F; Di Stefano L; Di Febbo G; D'Alfonso A; Di Fonso A; Carta G
Eur J Gynaecol Oncol; 2014; 35(1):87-90. PubMed ID: 24654471
[TBL] [Abstract][Full Text] [Related]
31. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
32. Management of placental site trophoblastic tumors.
Newlands ES; Bower M; Fisher RA; Paradinas FJ
J Reprod Med; 1998 Jan; 43(1):53-9. PubMed ID: 9475150
[TBL] [Abstract][Full Text] [Related]
33. Treatment of high-risk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine chemotherapy.
Escobar PF; Lurain JR; Singh DK; Bozorgi K; Fishman DA
Gynecol Oncol; 2003 Dec; 91(3):552-7. PubMed ID: 14675675
[TBL] [Abstract][Full Text] [Related]
34. High-risk metastatic gestational trophoblastic disease. A new dose-intensive, multiagent chemotherapeutic regimen.
Surwit EA; Childers JM
J Reprod Med; 1991 Jan; 36(1):45-8. PubMed ID: 1848900
[TBL] [Abstract][Full Text] [Related]
35. M-EA (methotrexate, etoposide, dactinomycin) and EMA-CO (methotrexate, etoposide, dactinomycin / cyclophosphamide, vincristine) regimens as first-line treatment of high-risk gestational trophoblastic neoplasia.
Singh K; Gillett S; Ireson J; Hills A; Tidy JA; Coleman RE; Hancock BW; Winter MC
Int J Cancer; 2021 May; 148(9):2335-2344. PubMed ID: 33210289
[TBL] [Abstract][Full Text] [Related]
36. Central nervous system involvement in gestational trophoblastic neoplasia.
Altintaş A; Vardar MA
Eur J Gynaecol Oncol; 2001; 22(2):154-6. PubMed ID: 11446484
[TBL] [Abstract][Full Text] [Related]
37. Placental site trophoblastic tumor--a challenging rare entity.
Piura B
Eur J Gynaecol Oncol; 2006; 27(6):545-51. PubMed ID: 17290581
[TBL] [Abstract][Full Text] [Related]
38. Importance of salvage therapy in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Schink JC
J Reprod Med; 2012; 57(5-6):219-24. PubMed ID: 22696816
[TBL] [Abstract][Full Text] [Related]
39. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
40. Placental site trophoblastic tumor: report of four cases and review of literature.
Piura B; Rabinovich A; Meirovitz M; Shaco-Levy R
Int J Gynecol Cancer; 2007; 17(1):258-62. PubMed ID: 17291263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
